21 C.F.R. § 341.18
Expectorant active ingredient.
Last amended: 2016Year: 2026Length: 24 wordsOfficial source Cite as 21 C.F.R. § 341.18 (2026)
The active ingredient of the product is guaifenesin when used within the dosage limits established in § 341.78(d).
[54 FR 8509, Feb. 28, 1989]
- Cross-references to the CFR
- 341.78